Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glasmacher

Showing results (1-10 of 414) with videos related to

Pageof 42
Sort By:
Supportive Cancer Therapy|July 17, 2008
Invasive fungal infections in patients with hematologic malignancies: the next stepsAxel Glasmacher
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|April 8, 2014
[Recommendation for vaccination against polio]Susanne Glasmacher
Cancer Treatment Reviews|April 3, 2003
High dose therapy may have no survival benefit over CHOEP primary chemotherapy for people with aggressive non-Hodgkin's lymphomaAxel Glasmacher
Krankenpflege Journal|October 17, 1998
[Etiology and diagnosis of fever of unknown origin]A Glasmacher
Cancer Treatment Reviews|August 25, 2004
Initial high dose chemotherapy plus autologous stem cell support improves survival outcomes compared with a standard CHOP regimen in people with higher intermediate risk aggressive lymphomaAxel Glasmacher
Physical Review. C, Nuclear Physics|June 1, 1992
Spin and parity measurements in 128,129LaCottle, Glasmacher, Kemper
Physical Review. C, Nuclear Physics|August 1, 1996
Many-body Coulomb perturbation of azimuthal alpha - alpha correlationsPopescu, Gelbke, Glasmacher
Mycoses|June 29, 2005
Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofunginGeorg Maschmeyer, Axel Glasmacher
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 22, 2008
[Quality of scientific advice to politics. Lecture at the Berlin-Brandenburg Academy of Science and Humanities]R Kurth, S Glasmacher
Physical Review. C, Nuclear Physics|July 1, 1993
Electron conversion coefficients in 127Ba and 130LaCottle, Glasmacher, Johnson, et al.
Pageof 42

Showing results (1-10 of 414) with videos related to

Sort By:
Pageof 42
Supportive Cancer Therapy|July 17, 2008
Invasive fungal infections in patients with hematologic malignancies: the next stepsAxel Glasmacher
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|April 8, 2014
[Recommendation for vaccination against polio]Susanne Glasmacher
Cancer Treatment Reviews|April 3, 2003
High dose therapy may have no survival benefit over CHOEP primary chemotherapy for people with aggressive non-Hodgkin's lymphomaAxel Glasmacher
Krankenpflege Journal|October 17, 1998
[Etiology and diagnosis of fever of unknown origin]A Glasmacher
Cancer Treatment Reviews|August 25, 2004
Initial high dose chemotherapy plus autologous stem cell support improves survival outcomes compared with a standard CHOP regimen in people with higher intermediate risk aggressive lymphomaAxel Glasmacher
Physical Review. C, Nuclear Physics|June 1, 1992
Spin and parity measurements in 128,129LaCottle, Glasmacher, Kemper
Physical Review. C, Nuclear Physics|August 1, 1996
Many-body Coulomb perturbation of azimuthal alpha - alpha correlationsPopescu, Gelbke, Glasmacher
Mycoses|June 29, 2005
Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofunginGeorg Maschmeyer, Axel Glasmacher
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 22, 2008
[Quality of scientific advice to politics. Lecture at the Berlin-Brandenburg Academy of Science and Humanities]R Kurth, S Glasmacher
Physical Review. C, Nuclear Physics|July 1, 1993
Electron conversion coefficients in 127Ba and 130LaCottle, Glasmacher, Johnson, et al.
Pageof 42